Akanda Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not
Akanda Akanda unveiled its unaudited financial figures for the six months to the end of June 2022, two weeks after
Akanda The NASDAQ-listed international medical cannabis operator announced last week that it will abandon its operations in Lesotho following a
WHILE last week’s news from the US saw many EU cannabis stocks experience a spike in stock price on Friday,
NEWS broke yesterday evening that US President Joe Biden has moved to federally pardon thousands of Americans with minor cannabis
INTERNATIONAL medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) expects to take a leading position in
Markets across Europe opened lower this morning as ongoing and increasingly severe reports of a looming economic crisis pushed the
INTERNATIONAL medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has signed a multi-year
AKANDA’s wholly owned subsidiary Bophelo Bioscience, which operates the company’s key cultivation facility in Lesotho, has been taken into liquidation
It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making progress
AS quarterly and full-year results continued to be published across the global cannabis industry, European stocks enjoyed a relatively stable
European cannabis stocks had another generally positive week last week, with some major announcements from the North American market prop-up
AKANDA Corp has become the latest British cannabis company to go public after it launched on the NASDAQ Stock Exchange this week, seeing its stock soar some 350% above its listing price.
At Akanda, Dr. Nayee will be responsible for monitoring and improving the overall level of care provided to medical patients in the UK, as well as helping assess expansion into other international markets.
Akanda Corp has announced that it has closed a private placement for aggregate gross proceeds of $5,316,000. The Company intends
HALO Collective Inc. (“Halo” or the “Company”) (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) today announced that it has entered into
ONE of the UK’s newest medical cannabis companies is set to launch its own medicine in a move which will
We won’t spam you
